STACEY SHAW: Open Payments
NPI 1093226789 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,350 in 85 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $13 · 2025 $1,350
Food & beverage: $1,350
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 11 | $311 |
| ABBVIE INC. | 34 | $295 |
| Otsuka America Pharmaceutical, Inc. | 14 | $207 |
| Alkermes, Inc. | 5 | $109 |
| Neurocrine BioSciences, Inc. | 4 | $83 |
| Collegium Pharmaceutical, Inc. | 4 | $76 |
| Teva Pharmaceuticals USA, Inc. | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $33 |
Products named: Qelbree, VRAYLAR, REXULTI, ARISTADA, INGREZZA, Jornay PM, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across SC — which companies pay providers there.
